Retroviral vectors that are both non-replicating and non-integrating represent a novel and attractive tool that has potential advantages for gene delivery therapy, immunotherapy, and vaccinology.

Daily first-run talk show Karamo will be back for a fourth season in national syndication, including multicast channel Bounce ...

For Uditi’s parents, reading about use of CRISPR tech, or ‘genetic scissors’, to treat baby KJ, diagnosed with severe genetic ...

Fares plays George Fahmy, the biggest movie star in Egypt. They call him “The Pharaoh of the Screen,” and that adoration has ...

In addition to complementing AAV manufacturing, the company’s Plasmid DNA (pDNA) platform is now available as a standalone ...

The deal gives Lilly access to the company’s RNA-editing platform to develop therapies for sensorineural hearing loss.

Plasmidsaurus, the company that sequences while you sleep, today announced the launch of a new product update that delivers full-length AAV genome sequences, including subgenomic variants, in just ...

GEN talked with several contract development and manufacturing organizations (CDMOs) and/or contract research organizations (CROs) about new ways they are addressing AAV manufacturing challenges.

AnelloBricks is a promising in vitro approach to producing a new class of functional viral vectors, offering dramatic advantages in manufacturing scalability and cost compared to ...

Biopharmas have been scaling back on AAV research for sometime now. Find out why and what's on the horizon for drug delivery ...